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 Butterfly-shaped pigment dystrophy of the fovea, also
named butterfly-shaped macular dystrophy (BSMD), was de-
scribed for the first time by Deutman and coworkers [1] and is
characterized by bilateral accumulation of pigmented or yel-
lowish material at the level of the retinal pigment epithelium
(RPE). Lesions consist of 3 to 5 “wings”, resembling the wings
of a butterfly. Fundamental for the diagnosis are a subnormal
electrooculogram (EOG), normal or only slightly diminished
visual acuity, and an autosomal dominant inheritance pattern.
Older patients can suffer from markedly reduced visual acu-
ity due to large retinal atrophic lesions in the macular area [2].
Several entities including BSMD, reticular dystrophy [3],
macroreticular dystrophy [4], fundus pulverulentus [5], and
adult-onset foveomacular vitelliform dystrophy [6] belong to
a group of autosomal dominant dystrophies of the RPE, known
as pattern dystrophies [7]. Variability of expression of pattern
dystrophy has been described within families [8-10] and in a
single patient during various stages of the disease [11]. So far
BSMD has only been associated with mutations in the
peripherin/RDS gene [12-19]. The purpose of this study is to
screen the original BSMD family for mutations in the
peripherin/RDS gene and to examine putative involvement of
the ROM-1 gene, four cone expressed genes, all known non-
syndromic autosomal dominant and recessive macular, RPE
and choroidal dystrophy loci, all known Leber congenital
amaurosis (LCA) loci, and all known non-syndromic congeni-
tal and stationary retinal disease loci.
METHODS
 Thirteen individuals from the original Dutch BSMD family
were included in this study. An informed consent was obtained
from all participating individuals. The medical histories were
obtained from two unaffected and eight affected individuals.
Subsequent ophthalmic examination included best corrected
Snellen visual acuity, slit-lamp biomicroscopy, fundus exami-
nation and fluorescein angiography. Five patients (II-1, II-3,
II-4, II-8, III-1) underwent electroretinography (ERG) and all
eight affected individuals EOG. ERG and EOG were recorded
and interpreted as previously described [1,20,21]. In three
patients, EOG was performed according to the International
Society for Clinical Electrophysiology of Vision protocol. In
addition five patients (II-1, II-3, II-4, II-8, III-1) underwent
color vision and dark adaptation testing.
For molecular analysis, blood samples of all participat-
ing individuals were collected and DNA was isolated as de-
scribed elsewhere [22]. For mutation analysis of the peripherin/
RDS gene, 25 ng of genomic DNA was amplified using the
polymerase chain reaction (PCR), under the following condi-
tions: initial denaturation 5 min at 95 °C, denaturation for 30
s at 94 °C, annealing for 30 s at 55 °C, extension for 1 min at
72 °C, and a final extension for 5 min at 72 °C. For peripherin/
RDS exon 1, part I (cDNA nucleotides 209-484) [23], we used
the forward primer 5'-GTG GGA AGC AAC CCG GAC-3',
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and the reverse primer 5'- AGA TCT TCC CAG CCA GCG-
3'. For exon 1, part II (cDNA nucleotides 431 - 673)[23], we
employed the forward primer 5'-TGA TAG GGA TGG GGG
TGC-3', and the reverse primer 5’CTG TGT CCC GGT AGT
ACT TC-3'. For exon 1, part III (starting at cDNA nucleotide
611), [23] we used the forward primer 5'-GCT CGC TGG AGA
ACA CCC T-3' and the reverse (intron 1) primer 5'-TCT GAC
CCC AGG ACT GGA AG-3' [23]. For exon 2, we used for-
ward primer (derived from 3' end of the first intron) 5'-AAG
CCC ATC TCC AGC TGT CT-3' and reverse primer (derived
from 5' end of the second intron) 5'-CTT ACC CTC TAC CCC
CAG CTG-3'. For exon 3 we used forward primer (derived
from 3' end of the second intron) 5'-AGA TTG CCT CTA AAT
CTC CTC-3' and reverse primer 5'-TGC ACT ATT TCT CAG
TGT TCG-3', located at cDNA nucleotides 1305 to 1325 of
the 3' untranslated region [24]. For exon 3, the reverse primer
5'-TGC ACT ATT TCT CAG TGT TCG-3' located at cDNA
nucleotides 1305 to 1325 of the 3' untranslated region was
used. Mutation analysis of the peripherin/RDS gene was per-
formed by direct sequencing using a BigDye Terminator chem-
istry on an ABI Prism 377 (PE Applied Biosystems). Flank-
ing microsatellite markers were chosen from the Généthon
database [25] to investigate the peripherin/RDS locus, the
ROM-1 locus, 19 autosomal dominant macular, RPE and cho-
roidal dystrophy loci, 9 autosomal recessive macular, RPE and
choroidal dystrophy loci and 8 LCA loci (Table 1 and Table
2). Furthermore, 8 autosomal dominant and recessive congeni-
tal and stationary retinal disease loci and four chromosomal
regions harboring cone photoreceptor expressed genes were
examined (Table 3 and Table 4). Finally, one syndromic auto-
somal recessive retinal degeneration locus at 4q24 (MTP) was
tested using microsatellite markers D4S414 and D4S411.
Samples were subjected to PCR amplification, with a stan-
dard cycling profile of 30 cycles at 94 °C, 55 °C, and 72 °C
with 30 s at each step. DNA markers were labeled by the in-
corporation of α[32P]-dCTP and the products were separated
by electrophoresis on a 6.6% denaturing polyacrylamide gel.
Haplotype analysis was performed and two-point LOD scores
were calculated using the subroutine Mlink of the Linkage
package [26-28]. Multipoint analysis was performed using
FASTLINK version 2.30 [29,30]. A gene frequency of 0.0001
and a penetrance of 95% were assumed for the disorder.
RESULTS
 The clinical features are summarized in Table 5. Visual acu-
ity was normal or nearly normal in all affected individuals
except individual II-8, who had a visual acuity of 20/50 in his
right eye and 20/200 in his left eye, but he also suffered from
a optic neuropathy, due to multiple sclerosis. Ophthalmoscopy
revealed pigmented butterfly-shaped structures in both eyes
in 6 affected individuals (II-1, II-3, II-4, II-8, III-1, III-4; Fig-
ure 1A,C). Individuals III-2 and III-5 had butterfly-shaped
pigmentations in one eye, and small pigment alterations with-
out any pattern in the other. The butterfly-shaped pigmenta-
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TABLE 1. AUTOSOMAL DOMINANT MACULAR, RPE AND CHOROIDAL DYSTROPHY LOCI
 Chromosomal
  location      Locus     Gene                   Phenotype                              Markers
-------------   ------   ------   ------------------------------------------   -------------------------
1q25-q31        ARMD1    -        Age-related macular degeneration             D1S238, F13B, D1S2683
2p16-p21        DHRD     EFEMP1   Dominant drusen/Doyne honeycomb retinal      D2S1771, D2S123
                                    dystrophy
4p              STGD4    -        Stargardt disease                            D4S2957, D4S431, D4S394,
                                                                                 D4S3048, D4S419, D4S230
6p21.1          COD3     GUCA1A   Cone dystrophy                               D6S1680, D6S1582
6p21.2-cen      -        RDS      Adult vitelliform macular dystrophy,         D6S1680, D6S1582, D6S1651
                                    Central areolar choroidal dystrophy,
                                    Cone-rod dystrophy, Pattern dystrophy
6q              CORD7    -        Cone-rod dystrophy                           D6S1681
6q14            STGD3    ELOVL4   Stargardt disease                            D6S1681, D6S1609, D6S1613
6q14-q16.2      MCDR1,   -        North Carolina macular dystrophy,            D6S1613, D6S300, D6S302
                PBCRA               Progressive bifocal chorioretinal
                                    atrophy
6q25-q26        RCD1     -        Cone dystrophy                               D6S290, D6S305
7p21-p15        CYMD     -        Cystoid macula dystrophy                     D7S2493, D7S673
11p15           AA       -        Atrophia areata/chorioretinal degeneration   D11S1318, D11S4149
11q13           VMD2     VMD2     Best disease                                 D11S1883, PYGM, D11S987
17p13           CACD     -        Central areolar choroidal dystrophy          D17S1528, D17S1876
17p13.1         CORD6    GUCY2D   Cone-rod dystrophy                           D17S1876, D17S786
17p13.1         -        AIPL1    Cone-rod dystrophy                           D17S1876, D17S786
17p13-p12       CORD5    -        Cone-rod dystrophy                           D17S786, D17S945
17q11.2         -        UNC119   Cone-rod dystrophy                           D17S798, D17S250
19q13.3         CORD2    CRX      Cone-rod dystrophy                           D19S867, D19S572
22q12.1-q13.2   SFD      TIMP3    Sorsby’s fundus dystrophy                    D22S281, D22S421
Autosomal dominant macular, RPE and choroidal dystrophy loci, listed by chromosomal location and the microsatellite markers used for
linkage analysis.
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tions seemed to be localized in the deeper layers of the retina
in or near the RPE. The retinal vessels continued their course
across the pigmentations. Individuals II-1, II-4 and II-8, which
were 70, 71 and 65 years old respectively at examination,
showed parafoveal chorioretinal atrophy, accompanied by
peripheral bone spicule-like structures in II-1 and II-4 (Figure
1D). Individual II-8 had developed some peripapillary atro-
phy. In individual II-3 many peripheral reticular pigmenta-
tions were seen (Figure 1E). Five patients had drusen-like al-
terations surrounding the butterfly-shaped pigmentations. Fluo-
rescein angiograms demonstrated clearly outlined
hypofluorescent butterfly-shaped structures in the macular area
in all patients (Figure 1B). The EOG was pathological (Arden
ration p95: >1.65) in all patients over age 35 years, except for
individual III-1, who already had a disturbed EOG from age
14. ERG, color vision and dark adaptation were normal in all
5 patients tested. The normal ERG values of the scotopic and
photopic b-wave amplitudes are stated in Table 5 [1].
Direct sequencing of the PCR products of the three exons
of the peripherin/RDS gene from cases II-8 and III-1 revealed
no mutations. Using haplotype analysis, the peripherin/RDS
gene could be excluded (Figure 2). No haplotype could be
deduced around the peripherin/RDS gene, that co-inherited
with the BSMD phenotype. Notably, individual III-2 had not
inherited the D6S426 / D6S1582 haplotype, that was shared
by the other affected individuals. The LOD score obtained by
multipoint linkage analysis was less than -2 in the entire
D6S426 / D6S282 interval. Subsequently, the ROM-1 gene,
the 4 cone genes, all 41 non-syndromic retinal disease loci
and the syndromic MTP locus at 4q24 could also be excluded
by haplotype analysis and multipoint linkage analysis. A LOD
score of -2 or less in the entire critical interval of the locus or
surrounding the gene was taken as proof that the loci were not
linked to the phenotype. Two loci (STGD4 and the GNB2 gene)
could not be excluded by multipoint linkage analysis. The lo-
cus for STGD4 at chromosome 4p was situated between mark-
ers D4S1582 and D4S2397. Using markers D4S2957, D4S431,
D4S394, D4S3048, D4S419 and D4S230, multipoint LOD
scores varying from -0.25 to -4.1 were obtained. Haplotype
analysis revealed three affected individuals that did not show
the at risk chromosome 4 haplotype (data not shown). Mark-
ers D7S646 and D7S662, flanking the GNB2 gene demon-
strated multipoint LOD scores varying from -0.5 to -1.6 be-
tween these markers. Haplotype analysis however revealed
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TABLE 2. AUTOSOMAL RECESSIVE MACULAR, RPE AND CHOROIDAL
DYSTROPHY LOCI AND LCA LOCI
Chromosomal
 location     Locus    Gene               Disease                    Markers
-----------   -----   -------   ---------------------------   ---------------------
1p31          LCA2    RPE65     Leber congenital amaurosis    D1S246, D1S430
1p21-22       STGD1   ABCA4     Stargardt disease, cone-rod   D1S424, D1S497
                                  dystrophy
1q12-24       CORD8   -         Cone-rod dystrophy            D1S506, APOA2, D1S194
1q31-q32.1    -       CRB1      Leber congenital amaurosis    F13B, D1S238, D1S2683
4p16.2        -       PROML1    Retinal degeneration          D4S3048, D4S419
6q11-q16      LCA5    -         Leber congenital amaurosis    D6S1681, D6S1609,
                                                                D6S1613, D6S300
8p11          CORD9   -         Cone-rod dystrophy            D8S1771, D8S1810,
                                                                D8S87, D8S1737
10q24         -       RBP4      RPE degeneration              D10S583, D10S603
10q26         -       OAT       Gyrate atrophy                D10S534, D10S187
12q13-q14     -       RDH5      Cone dystrophy                D12S1618, D12S1691
14q11         -       RPGRIP1   Leber congenital amaurosis    D14S50, D14S1032,
                                                                D14S80
14q24         LCA3    -         Leber congenital amaurosis    D14S999, D14S287,
                                                                D14S48, D14S81
15q26         -       RLBP1     Bothnia dystrophy             D15S115, D15S202
17p13-p12     RCD2    -         Cone-rod dystrophy            D17S786, D17S945
17p13.1       LCA4    AIPL1     Leber congenital amaurosis    D17S1876, D17S786
17p13.1       LCA1    GUCY2D    Leber congenital amaurosis    D17S1876, D17S786
19q13.3       -       CRX       Leber congenital amaurosis    D19S867, D19S572
Autosomal recessive macular, RPE and choroidal dystrophy loci and
Leber congenital amaurosis loci, listed by chromosomal location and
the microsatellite markers used for linkage analysis.
TABLE 3. CONGENITAL AND STATIONARY RETINAL DISEASE LOCI
Chromosomal
 location     AD/AR   Locus    Gene              Disease                 Markers
-----------   -----   -----   ------   ---------------------------   ----------------
3p22           AD     -       GNAT1    Congenital stationary night   D3S1298, D3S1289
                                         blindness
3q21-q24       AD     -       RHO      Congenital stationary night   D3S3607, D3S1292
                                         blindness
4p16.3         AD     CSNB3   PDE6B    Congenital stationary night   D4S1614, D4S2957
                                         blindness
7q31.3-q32     AD     -       OPN1SW   Tritanopia                    D7S480, D7S635
1p13.1         AR     -       GNAT2    Achromatopsia                 D1S248, D1S250
2q11           AR     ACHM2   CNGA3    Achromatopsia                 D2S113
8q21-q22       AR     ACHM3   CNGB3    Achromatopsia                 D8S275, D8S167
15q23          AR     ESCS    NR2E3    Enhanced S-cone syndrome      D15S131, D15S115
Autosomal dominant (AD) and recessive (AR) congenital and sta-
tionary retinal disease loci, listed by chromosomal location and the
microsatellite markers used for linkage analysis.
TABLE 4. ROM1 AND CONE SPECIFIC GENES
Chromosomal
 location     Gene                    Markers
-----------   -----   ---------------------------------------
11q13         ROM1    D11S1883, PYGM
7q21          GNB2    COL1A2, D7S479, D7S646, D7S662, D7S2504
10q24         PDE6C   D10S583
12p13         PDE6H   D12S169, D12S364
17q21         GNGT2   D17S1827, D17S1820, D17S1606
ROM1 and cone specific genes, listed by chromosomal location and
the microsatellite markers used for linkage analysis.
TABLE 5. CLINICAL DETAILS OF THE BSMD FAMILY
                     Visual acuity    Scotopic    Photopic        EOG
        Exam         --------------   ---------   ---------   -----------
Pt.     year   Age    OD       OS     OD    OS    OD    OS     OD     OS    DAE
-----   ----   ---   -----   ------   ---   ---   ---   ---   ----   ----   ---
II-1    1968   43    20/20   20/20    285   305   125   120   1.6    1.5     N
        1995   70    20/25   20/20    -     -     -     -     -      -       -
II-3    1968   42    20/20   20/20    205   285   135   110   1.0    1.0     N
        1994   68    20/20   20/25    -     -     -     -     -      -       -
II-4    1968   38    20/20   20/20    325   345   135   135   1.3    1.3     N
        2001   71    20/20   20/20    -     -     -     -     -      -       -
II-8    1968   32    20/25   20/20    320   260   130   120   1.85   1.95    N
        2001   65    20/50   20/200   -     -     -     -     -      -       -
III-1   1968   14    20/25   20/25    435   355   145   120   1.4    1.45    N
III-2   2001   40    20/40   20/16    -     -     -     -     1.35   1.41    -
III-4   2001   35    20/20   20/40    -     -     -     -     1.44   1.46    -
III-5   2001   26    20/25   20/25    -     -     -     -     1.78   1.65    -
Scotopic: ERG scotopic b-wave amplitudes in µV (Normal: >200 µV)
Photopic: ERG photopic b-wave amplitudes in µV (Normal: >80 µV)
EOG: electro-oculography (Arden ration p95: >1.65)
DAE: dark adaptation elevation
Clinical details of the affected BSMD family members, including
visual acuity, EOG, ERG and dark-adaptation results
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one affected and one unaffected individual who did not carry
the same haplotype of the chromosome 7 interval containing
the GNB2 gene (data not shown).
DISCUSSION
 In this family with BSMD, the main clinical features were
the butterfly shaped macular lesions, the relatively good vi-
sual acuity and the disturbed EOG, while the ERG, color vi-
sion and dark adaptation were normal. Only in individual II-8
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Figure 1. Fundus photographs and fluorescence angiography of af-
fected BSMD family members.  A: Fundus photograph of patient
III-5 at age 16 years showing a black butterfly-shaped structure. B:
Fluorescence angiography of individual III-5, showing a striking pig-
mented structure in front of a brightly fluorescent choroid. C: Fun-
dus photograph of patient II-4 at age 52 years showing a more or less
butterfly-shaped, slightly pigmented structure. D: Peripheral bone
spicule-like structures and some parafoveal chorioretinal atrophy in
patient II-4. E: Peripheral reticular pigmentations in patient II-3.
      
141
a diminished visual acuity was found but he also suffered from
an optic neuropathy. BSMD shares important similarities with
age-related macular degeneration, since in both an abnormal
deposition of lipofuscin-like material at the level of the RPE
is found, which results in the loss of the overlying photore-
ceptors.
In several families with pattern dystrophy (among which
BSMD), mutations have been found in the peripherin/RDS
gene. These include the missense mutations Gly167Asp,
Pro210Arg, Pro216Ser, and Cys213Tyr, as well as the protein
truncating mutations Gln331stop, a 4-base pair (bp) deletion
at codon 140, a 2-bp frameshift deletion at codon 290, a 2-bp
frameshift deletion at codons 299/300, and a large deletion
that removes exons 2 and 3 of the peripherin/RDS gene [12-
19]. The BSMD family described in this study has no muta-
tions in the peripherin/RDS gene. Sequence analysis would
not be able to identify a heterozygous deletion of the
peripherin/RDS gene. We therefore performed linkage analy-
sis with markers flanking the peripherin/RDS gene, but found
no fully cosegregating haplotypes. A Swiss family with pat-
tern dystrophy has been reported in which the genetic defect
shows no linkage to the peripherin/RDS gene nor to the rhodop-
sin gene, but the phenotype of this family has not been de-
scribed [31].
Because peripherin-2, the protein product of the
peripherin/RDS gene forms a heterotetramer with ROM-1, the
ROM-1 gene was considered a candidate gene for BSMD. The
heterotetrameric peripherin-2/ ROM-1 complex is important
for rod photoreceptor disk morphogenesis and mutations in
both components result in a defective subunit assembly of the
heterotetrameric peripherin-2/ROM-1 complex [32]. Non-al-
lelic heterozygous peripherin/RDS and ROM-1 mutations
cause digenic RP [33]. Linkage analysis however excluded
the involvement of ROM-1 in this BSMD family.
The VMD2 gene, associated with Best disease, was con-
sidered another good candidate gene, because BSMD and Best
disease have been found within the same patient and within
the same family [8-10]. Moreover Best disease and BSMD
share the presence of hyperpigmented material in the RPE, a
subnormal EOG, a normal ERG and an autosomal dominant
pattern of inheritance [34,35]. The VMD2 gene is located on
chromosome 11q13 [36,37]. Nevertheless, this family showed
no linkage to markers flanking the VMD2 gene.
Subsequent linkage analysis excluded all other macular,
RPE, and choroidal dystrophy loci, the LCA loci, the con-
genital and stationary retinal disease loci, and 4 genes ex-
pressed in cones including the β-subunit of guanine nucle-
otide binding protein (GNB2), the β-subunit of guanine nucle-
otide binding protein (GNGT2) and the α and β subunits of
cone cGMP phosphodiesterase 6H (PDE6C and PDE6H) [38-
42].
In this study we present clear evidence of genetic hetero-
geneity for BSMD. We could exclude not only the peripherin/
RDS gene, but all other known macular, RPE and choroidal
dystrophy loci, all known LCA loci and all known congenital
and stationary retinal disease loci. In the future we will ex-
pand the BSMD family which will enable us to perform a
whole genome linkage scan.
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